We are live on ! Find out more
Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $97.9B
1-Year Est. Return 20.73%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Fund
S&P 500
This Quarter Est. Return
+5.65%
1 Year Est. Return
+20.73%
3 Year Est. Return
+127.31%
5 Year Est. Return
+136.48%
10 Year Est. Return
+1,577.48%
AUM
$33B
AUM Growth
Cap. Flow
+$32.7B
Cap. Flow %
99.24%
Top 10 Hldgs %
46.9%
Holding
187
New
187
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$3.13B
2
BIDU icon
Baidu
BIDU
+$2.8B
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.79B
4
EBAY icon
eBay
EBAY
+$1.54B
5
ISRG icon
Intuitive Surgical
ISRG
+$1.14B

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 24.85%
2 Communication Services 21.48%
3 Financials 10.72%
4 Healthcare 10.4%
5 Technology 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NPSP
151
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$380K ﹤0.01%
+25,173
New +$349K
REGN icon
152
Regeneron Pharmaceuticals
REGN
$78.5B
$376K ﹤0.01%
+1,672
New +$389K
ESI
153
DELISTED
ITT EDUCATIONAL SERVICES INC
ESI
$365K ﹤0.01%
+14,949
New +$308K
POWI icon
154
Power Integrations
POWI
$3.38B
$345K ﹤0.01%
+17,000
New +$354K
BMRN icon
155
BioMarin Pharmaceuticals
BMRN
$11.6B
$332K ﹤0.01%
+5,949
New +$371K
PRDO icon
156
Perdoceo Education
PRDO
$1.99B
$284K ﹤0.01%
+98,062
New +$256K
WH
157
DELISTED
WSP HOLDINGS LTD ADR NEW
WH
$279K ﹤0.01%
+90,400
New +$278K
HSP
158
DELISTED
HOSPIRA INC
HSP
$275K ﹤0.01%
+7,191
New +$243K
A icon
159
Agilent Technologies
A
$39.1B
$270K ﹤0.01%
+8,813
New +$274K
ONXX
160
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
$267K ﹤0.01%
+3,079
New +$283K
ADSK icon
161
Autodesk
ADSK
$49.5B
$253K ﹤0.01%
+7,441
New +$277K
GIVN
162
DELISTED
GIVEN IMAGING LTD
GIVN
$243K ﹤0.01%
+17,341
New +$264K
IL
163
DELISTED
IntraLinks Holdings Inc.
IL
$240K ﹤0.01%
+33,000
New +$202K
NOAH
164
Noah Holdings
NOAH
$580M
$239K ﹤0.01%
+27,000
New +$263K
HOLX
165
DELISTED
Hologic
HOLX
$232K ﹤0.01%
+12,045
New +$252K
SCR
166
DELISTED
SIMCERE PHARMACEUTICAL GROUP, ADS
SCR
$231K ﹤0.01%
+24,400
New +$226K
HOGS
167
DELISTED
ZHONGPIN INC COM STK
HOGS
$225K ﹤0.01%
+16,682
New +$218K
AMED
168
DELISTED
Amedisys
AMED
$222K ﹤0.01%
+19,129
New +$219K
CPHD
169
DELISTED
Cepheid Inc
CPHD
$185K ﹤0.01%
+5,367
New +$197K
GAME
170
DELISTED
SHANDA GAMES LTD SPON ADR REPSTG CL A (CAYMAN ISLANDS)
GAME
$183K ﹤0.01%
+46,300
New +$154K
XRTX
171
DELISTED
XYRATEX LTD (BERMUDA)
XRTX
$176K ﹤0.01%
+17,456
New +$186K
SQNM
172
DELISTED
SEQUENOM INC NEW
SQNM
$173K ﹤0.01%
+41,194
New +$165K
DGX icon
173
Quest Diagnostics
DGX
$25.7B
$162K ﹤0.01%
+2,665
New +$159K
MDVN
174
DELISTED
MEDIVATION, INC.
MDVN
$155K ﹤0.01%
+6,296
New +$158K
EMAN
175
DELISTED
eMagin Corporation
EMAN
$142K ﹤0.01%
+40,000
New +$140K

Similar funds

Baillie Gifford & Co's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Baillie Gifford & Co, which disclosed 187 positions worth $33B. Its ten largest holdings account for 47% of the portfolio.

Its largest position is Amazon: 235,345,400 shares worth $3.27B.

By sector, the portfolio is most concentrated in Consumer Discretionary at 25% of assets, followed by Communication Services and Financials.

  • Baillie Gifford & Co's largest Q2 2013 buy was Amazon: 235,345,400 shares worth $3.27B.
  • Baillie Gifford & Co's ten largest holdings make up 47% of its $33B portfolio in Q2 2013.
  • Baillie Gifford & Co disclosed 187 positions in Q2 2013, its first 13F filing on record.

Based on Baillie Gifford & Co's 13F filing for Q2 2013, filed 7 Aug 2013.